Subscribe To
Cabaletta bio announces pricing of public offering of common stock
PHILADELPHIA, May 17, 2023 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnol...
May 18, 2023, 2:16 am
Immupharama eyes clinical trial progress
ImmuPharama PLC's focus for the current year will be on moving Lupuzor, its treatment for the autoimmune...
May 11, 2023, 3:06 am
Immunic, inc. to announce financial results for the first quarter ended march 31, 2023, and provide corporate update
– Webcast to be Held at 8:00 am ET on May 11, 2023 – NEW YORK , May 9, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology compan...
May 9, 2023, 6:30 am
Cabaletta bio to present at the american society of gene and cell therapy 26th annual meeting
PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and l...
May 2, 2023, 8:35 pm
Cabaletta bio to present at the american society of gene and cell therapy 26th annual meeting
PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and la...
May 2, 2023, 4:35 pm
Argenx to present at bofa securities 2023 health care conference
May 2 , 202 3 Amsterdam , the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people...
May 2, 2023, 1:00 am
Selecta biosciences to host conference call and webcast to discuss first quarter 2023 financial results and provide business update
WATERTOWN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically vali...
April 28, 2023, 4:05 pm
Immunic inc announces appointment of dr richard rudick to board of directors
Immunic Inc (NASDAQ:IMUX) has announced the appointment of Dr Richard Rudick to its board of directors, effective April 26, 2023. The biotechnology c...
April 27, 2023, 8:32 am
Argenx to report first quarter 2023 financial results and business update on may 4, 2023
April 27 , 202 3 Amsterdam , the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peo...
April 27, 2023, 1:00 am
Why shares of prometheus biosciences are soaring monday
Prometheus' lead therapy treats ulcerative colitis and a variety of autoimmune disorders. Merck is look...
April 17, 2023, 12:09 pm
Merck strengthens immunology pipeline with acquisition of prometheus biosciences, inc.
PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune...
April 16, 2023, 10:00 am
Alvotech (alvo) declines on crl for humira's biosimilar candidate
Alvotech's shares decline as it receives a complete response letter for biosimilar candidate, AVT02, treating ...
April 14, 2023, 3:12 pm
Akari therapeutics to host key opinion leader webinar on geographic atrophy and the potential of long-acting pas-nomacopan to address significant unmet needs
Event on May 22nd will feature Elias Reichel, M.D., Professor, Department of Ophthalmology, Tufts University School of Medicine NEW YORK and LONDON, A...
April 14, 2023, 12:00 pm
Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1
Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and ...
April 12, 2023, 8:05 pm
Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1
Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and ...
April 12, 2023, 8:05 pm
Celldex therapeutics to present at h.c. wainwright autoimmune & inflammatory disease virtual conference
HAMPTON, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fires...
March 29, 2023, 9:01 am
Aclaris therapeutics to participate in the h.c. wainwright autoimmune & inflammatory disease virtual conference
WAYNE, Pa., March 27, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on develo...
March 27, 2023, 7:00 am
Alpine immune sciences to present povetacicept (alpn-303) phase 1 (ruby-1) study data and clinical pharmacokinetic & pharmacodynamic modeling at upcoming scientific conferences
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...
March 20, 2023, 4:30 pm
Biondvax to present at bio-europe spring
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd . (Nasdaq: BVXV), a biopharmaceutical company focused...
March 16, 2023, 1:10 pm
Alpine immune sciences to report fourth quarter and full year 2022 financial results
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...
March 15, 2023, 4:30 pm